Literature DB >> 18996447

The distribution of gamma-hydroxybutyrate-induced Fos expression in rat brain: comparison with baclofen.

P S van Nieuwenhuijzen1, I S McGregor, G E Hunt.   

Abstract

gamma-Hydroxybutyrate (GHB) is a euphoric, prosocial and sleep inducing drug that binds with high affinity to its own GHB receptor site and also more weakly to GABA(B) receptors. GHB is efficacious in the treatment of narcolepsy and alcoholism, but heavy use can lead to dependence and withdrawal. Many effects of GHB (sedation, hypothermia, catalepsy) are mimicked by GABA(B) receptor agonists (e.g. baclofen). However other effects (euphoric and prosocial effects and a therapeutic effect in narcolepsy) are not. The present study used Fos immunohistochemistry to assess the neural activation produced in rat brain by medium to high doses of GHB (250, 500 and 1000 mg/kg) and a high dose of baclofen (10 mg/kg) that produced similar sedation to 500 mg/kg GHB. Results showed many common regions of activation with these two drugs including the supraoptic, paraventricular, median preoptic and ventral premammillary nuclei of the hypothalamus, the central nucleus of the amygdala, Edinger-Westphal nucleus, lateral parabrachial nucleus, locus coeruleus, and nucleus of the solitary tract. GHB (500 mg/kg), but not baclofen (10 mg/kg), induced significant Fos expression in the median raphe nucleus and lateral habenula, while a higher dose of GHB (1000 mg/kg) induced additional Fos expression in the islands of Calleja, dentate gyrus (polymorphic layer) and arcuate nucleus, and in various regions implicated in rapid and non-rapid eye movement sleep (laterodorsal tegmental nucleus, tuberomammillary nucleus and the ventrolateral and anterodorsal preoptic nuclei). Surprisingly, Fos immunoreactivity was not observed with either GHB or baclofen in reward-relevant regions such as the nucleus accumbens, striatum and ventral tegmental area. Overall these results indicate a distinctive signature of brain activation with GHB that may be only partly due to GABA(B) receptor effects. This confirms a unique neuropharmacological profile for GHB and indicates key neural substrates that may underlie its characteristic influence on sleep, body temperature, sociability and endocrine function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18996447     DOI: 10.1016/j.neuroscience.2008.10.011

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  14 in total

Review 1.  Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy.

Authors:  Steven T Szabo; Michael J Thorpy; Geert Mayer; John H Peever; Thomas S Kilduff
Journal:  Sleep Med Rev       Date:  2018-11-08       Impact factor: 11.609

2.  New synthesis and tritium labeling of a selective ligand for studying high-affinity γ-hydroxybutyrate (GHB) binding sites.

Authors:  Stine B Vogensen; Aleš Marek; Tina Bay; Petrine Wellendorph; Jan Kehler; Christoffer Bundgaard; Bente Frølund; Martin H F Pedersen; Rasmus P Clausen
Journal:  J Med Chem       Date:  2013-10-04       Impact factor: 7.446

3.  Residual social, memory and oxytocin-related changes in rats following repeated exposure to γ-hydroxybutyrate (GHB), 3,4-methylenedioxymethamphetamine (MDMA) or their combination.

Authors:  Petra S van Nieuwenhuijzen; Leonora E Long; Glenn E Hunt; Jonathon C Arnold; Iain S McGregor
Journal:  Psychopharmacology (Berl)       Date:  2010-08-21       Impact factor: 4.530

Review 4.  The Edinger-Westphal nucleus: a historical, structural, and functional perspective on a dichotomous terminology.

Authors:  Tamás Kozicz; Jackson C Bittencourt; Paul J May; Anton Reiner; Paul D R Gamlin; Miklós Palkovits; Anja K E Horn; Claudio A B Toledo; Andrey E Ryabinin
Journal:  J Comp Neurol       Date:  2011-06-01       Impact factor: 3.215

5.  Differential effects of GABAB receptor subtypes, {gamma}-hydroxybutyric Acid, and Baclofen on EEG activity and sleep regulation.

Authors:  Julie Vienne; Bernhard Bettler; Paul Franken; Mehdi Tafti
Journal:  J Neurosci       Date:  2010-10-20       Impact factor: 6.167

Review 6.  The habenula: from stress evasion to value-based decision-making.

Authors:  Okihide Hikosaka
Journal:  Nat Rev Neurosci       Date:  2010-07       Impact factor: 34.870

7.  α4βδ GABA(A) receptors are high-affinity targets for γ-hydroxybutyric acid (GHB).

Authors:  Nathan Absalom; Laura F Eghorn; Inge S Villumsen; Nasiara Karim; Tina Bay; Jesper V Olsen; Gitte M Knudsen; Hans Bräuner-Osborne; Bente Frølund; Rasmus P Clausen; Mary Chebib; Petrine Wellendorph
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-02       Impact factor: 11.205

8.  GABAB agonism promotes sleep and reduces cataplexy in murine narcolepsy.

Authors:  Sarah Wurts Black; Stephen R Morairty; Tsui-Ming Chen; Andrew K Leung; Jonathan P Wisor; Akihiro Yamanaka; Thomas S Kilduff
Journal:  J Neurosci       Date:  2014-05-07       Impact factor: 6.167

9.  Differential development of tolerance to the functional and behavioral effects of repeated baclofen treatment in rats.

Authors:  T J R Beveridge; H R Smith; L J Porrino
Journal:  Pharmacol Biochem Behav       Date:  2013-03-13       Impact factor: 3.533

10.  Differential sensitivity of the perioculomotor urocortin-containing neurons to ethanol, psychostimulants and stress in mice and rats.

Authors:  E Spangler; D M Cote; A M J Anacker; G P Mark; A E Ryabinin
Journal:  Neuroscience       Date:  2009-02-25       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.